NYSE:GMRE - Global Medical REIT Stock Price, News & Analysis

$11.01
+0.22 (+2.04 %)
(As of 08/18/2019 09:41 AM ET)
Today's Range
$10.57
Now: $11.01
$11.03
50-Day Range
$10.17
MA: $10.50
$10.98
52-Week Range
$8.15
Now: $11.01
$11.51
Volume171,900 shs
Average Volume215,247 shs
Market Capitalization$389.75 million
P/E Ratio14.20
Dividend Yield7.41%
Beta0.41
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone202-524-6851

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$53.19 million
Cash Flow$1.5144 per share
Book Value$8.10 per share

Profitability

Net Income$13.49 million

Miscellaneous

EmployeesN/A
Market Cap$389.75 million
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable

Receive GMRE News and Ratings via Email

Sign-up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter.


Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Monday, June 17th. Stockholders of record on Wednesday, June 26th will be paid a dividend of $0.20 per share on Thursday, July 11th. This represents a $0.80 annualized dividend and a dividend yield of 7.27%. The ex-dividend date of this dividend is Tuesday, June 25th. View Global Medical REIT's Dividend History.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc (NYSE:GMRE) issued its earnings results on Wednesday, August, 7th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.19 by $0.16. The business had revenue of $16.88 million for the quarter, compared to analyst estimates of $16.74 million. Global Medical REIT had a net margin of 24.11% and a return on equity of 5.91%. View Global Medical REIT's Earnings History.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Global Medical REIT.

What price target have analysts set for GMRE?

5 equities research analysts have issued 1-year price objectives for Global Medical REIT's shares. Their forecasts range from $9.03 to $11.00. On average, they expect Global Medical REIT's stock price to reach $10.6060 in the next year. This suggests that the stock has a possible downside of 3.7%. View Analyst Price Targets for Global Medical REIT.

What is the consensus analysts' recommendation for Global Medical REIT?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Global Medical REIT.

What are Wall Street analysts saying about Global Medical REIT stock?

Here are some recent quotes from research analysts about Global Medical REIT stock:
  • 1. According to Zacks Investment Research, "Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. " (7/11/2019)
  • 2. Boenning Scattergood analysts commented, "We think that GMRE could have purchasing power remaining, on the order of $25 million to $35 million, and that incremental acquisition activity in 2019 will be funded by the newly expanded credit facility and ATM offerings. While GMRE’s portfolio acquisition offered an attractive ROI, we think that future acquisitions will be one-off properties — probably medical office – priced around its sweet spot of $10 million on average. Based on what we know about the timing of acquisitions in April and what we estimate in terms of acquisition activity over the balance of the year, we are raising our forward NAV estimate from $10.30 to $10.50." (5/10/2019)

Has Global Medical REIT been receiving favorable news coverage?

Media stories about GMRE stock have been trending negative on Sunday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Global Medical REIT earned a news sentiment score of -2.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Global Medical REIT.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a decrease in short interest in the month of July. As of July 31st, there was short interest totalling 389,500 shares, a decrease of 18.3% from the June 30th total of 476,600 shares. Based on an average daily trading volume, of 282,600 shares, the short-interest ratio is currently 1.4 days. Approximately 2.6% of the company's stock are sold short. View Global Medical REIT's Current Options Chain.

Who are some of Global Medical REIT's key competitors?

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Insys Therapeutics (INSY), Principal Financial Group (PFG), Square (SQ), General Electric (GE), Big Lots (BIG), Cypress Semiconductor (CY), Ritter Pharmaceuticals (RTTR), Sangamo Therapeutics (SGMO), AT&T (T) and New Residential Investment (NRZ).

Who are Global Medical REIT's key executives?

Global Medical REIT's management team includes the folowing people:
  • Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
  • Danica Holley, Chief Operating Officer
  • Robert J. Kiernan, Chief Financial Officer & Treasurer
  • Alfonzo Leon, Chief Investment Officer
  • Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.63%), Vanguard Group Inc. (5.88%), State of New Jersey Common Pension Fund D (2.03%), Wells Fargo & Company MN (1.80%), Psagot Investment House Ltd. (1.67%) and Marshall Wace LLP (1.49%). Company insiders that own Global Medical REIT stock include Henry Cole, Jeffrey Busch, Matthew Cypher, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View Institutional Ownership Trends for Global Medical REIT.

Which major investors are selling Global Medical REIT stock?

GMRE stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Marshall Wace LLP, BB&T Securities LLC, Renaissance Technologies LLC, Morgan Stanley, Invesco Ltd., Psagot Investment House Ltd. and ClariVest Asset Management LLC. View Insider Buying and Selling for Global Medical REIT.

Which major investors are buying Global Medical REIT stock?

GMRE stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, Nuveen Asset Management LLC, Vanguard Group Inc., United Services Automobile Association, Charles Schwab Investment Management Inc., Victory Capital Management Inc. and National Investment Services Inc. WI. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Jeffrey Busch, Matthew Cypher, Ronald Marston and Zh Usa, Llc. View Insider Buying and Selling for Global Medical REIT.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $11.01.

How big of a company is Global Medical REIT?

Global Medical REIT has a market capitalization of $389.75 million and generates $53.19 million in revenue each year. The company earns $13.49 million in net income (profit) each year or $0.78 on an earnings per share basis. View Additional Information About Global Medical REIT.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is http://www.globalmedicalreit.com/.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.


MarketBeat Community Rating for Global Medical REIT (NYSE GMRE)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  210 (Vote Outperform)
Underperform Votes:  228 (Vote Underperform)
Total Votes:  438
MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote "Outperform" if you believe GMRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel